Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France?

Infect Dis Now. 2021 Aug;51(5):407-409. doi: 10.1016/j.idnow.2021.05.001. Epub 2021 May 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • France
  • Humans
  • Infant
  • Meningococcal Infections*
  • Meningococcal Vaccines*
  • Neisseria meningitidis, Serogroup B*

Substances

  • Meningococcal Vaccines